• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莱顿因子 V:静脉血栓栓塞风险有多大?

Factor V Leiden: how great is the risk of venous thromboembolism?

机构信息

Department of Medicine, Case Western Reserve University-St. Vincent Charity Medical Center, Cleveland, OH 44115, USA.

出版信息

Cleve Clin J Med. 2012 Apr;79(4):265-72. doi: 10.3949/ccjm.79a.11072.

DOI:10.3949/ccjm.79a.11072
PMID:22473726
Abstract

The factor V Leiden mutation, the most common inherited cause of thrombophilia, causes a mild hypercoagulable state. We describe a 29-year-old man, heterozygous for factor V Leiden, who developed extensive pulmonary emboli with concomitant bilateral deep venous thrombosis, likely provoked by prolonged immobility during a car trip. We then review the diagnosis, therapy, screening, and prognosis of venous thromboembolism related to factor V Leiden.

摘要

凝血因子 V 莱顿突变是最常见的遗传性血栓形成倾向原因,可导致轻度高凝状态。我们描述了一位 29 岁的男性,因子 V 莱顿杂合子,在汽车旅行中长时间不动后,可能引发了广泛的肺栓塞伴双侧深静脉血栓形成。然后,我们回顾了与凝血因子 V 莱顿相关的静脉血栓栓塞症的诊断、治疗、筛查和预后。

相似文献

1
Factor V Leiden: how great is the risk of venous thromboembolism?莱顿因子 V:静脉血栓栓塞风险有多大?
Cleve Clin J Med. 2012 Apr;79(4):265-72. doi: 10.3949/ccjm.79a.11072.
2
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.静脉血栓栓塞症和因子 V 莱顿或凝血酶原 20210 突变携带者在抗凝过程中的患者结局。
Am J Med. 2017 Apr;130(4):482.e1-482.e9. doi: 10.1016/j.amjmed.2016.11.016. Epub 2016 Dec 14.
3
Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.杂合子和纯合子因子 V 莱顿突变携带者之间的静脉血栓栓塞事件和复发风险是否真的不同?一项回顾性队列研究。
Eur J Intern Med. 2016 May;30:77-81. doi: 10.1016/j.ejim.2016.02.023. Epub 2016 Mar 9.
4
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.凝血因子V莱顿突变与凝血酶原20210A联合作用对静脉血栓栓塞风险的影响——对8项病例对照研究的汇总分析,包括2310例病例和3204例对照。静脉血栓栓塞汇总分析研究组
Thromb Haemost. 2001 Sep;86(3):809-16.
5
Classic thrombophilic gene variants.经典的易栓症基因变异体
Thromb Haemost. 2015 Nov;114(5):885-9. doi: 10.1160/TH15-02-0141. Epub 2015 May 28.
6
Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.患有因子V莱顿突变的静脉血栓栓塞症患者一级亲属的凝血酶生成:一项初步研究。
Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515.
7
Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.携带因子 V 莱顿或凝血酶原 G20210A 突变的患者与无突变患者的静脉血栓栓塞类型和位置。
Clin Appl Thromb Hemost. 2010 Feb;16(1):66-70. doi: 10.1177/1076029608320721. Epub 2008 Sep 15.
8
Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?杂合子因子V莱顿突变和凝血酶原G20210A突变对静脉血栓栓塞的类型和部位是否有不同影响?
Int Angiol. 2014 Aug;33(4):404-5.
9
The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.静脉血栓栓塞症不同临床表现的血栓形成倾向模式:443 例静脉血栓栓塞症调查。
Semin Thromb Hemost. 2012 Mar;38(2):230-4. doi: 10.1055/s-0032-1301420. Epub 2012 Feb 8.
10
Factor V Leiden: a case study and review.
Dimens Crit Care Nurs. 2010 Jan-Feb;29(1):6-10. doi: 10.1097/DCC.0b013e3181be4985.

引用本文的文献

1
Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience.血栓形成倾向危险因素和 AB0 血型分布与终末期肾病患者动静脉内瘘失功的相关性:一项单中心经验。
Ren Fail. 2022 Dec;44(1):34-42. doi: 10.1080/0886022X.2021.2011746.
2
Direct oral anticoagulant treatment of deep vein thrombosis reduces IL-6 expression in peripheral mono-nuclear blood cells.直接口服抗凝剂治疗深静脉血栓可降低外周血单核细胞中白细胞介素-6的表达。
Exp Ther Med. 2020 Dec;20(6):237. doi: 10.3892/etm.2020.9367. Epub 2020 Oct 21.
3
An Uncommon Case of Lower Limb Deep Vein Thrombosis with Multiple Etiological Causes.
一例病因多样的下肢深静脉血栓形成罕见病例。
Am J Case Rep. 2017 Mar 28;18:313-316. doi: 10.12659/ajcr.902391.
4
Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population.静脉血栓栓塞症患者的遗传风险因素:伊朗人群的回顾性病例对照研究。
Thromb J. 2015 Nov 10;13:35. doi: 10.1186/s12959-015-0064-y. eCollection 2015.
5
Right Ventricular Thrombus in a 36-Year-Old Man with Factor V Leiden.一名36岁患有因子V莱顿突变的男性患者的右心室血栓形成
J Tehran Heart Cent. 2015;10(1):46-9. Epub 2015 Jan 8.